TODAY'S HEADLINES
Not unexpectedly, in May Drug Topics readers were drawn to stories written by their peers, as five of the top 10 stories were opinion pieces. With a promotional assist from The Cynical Pharmacist, Kim Ankenbruck's blog "A dose of pharmacy truth: Report from the front lines" was our most-read story in May.
» More
|
|
Citing medical literacy research pointing to consumers having an increasingly difficult time understanding Rx labels, The California Board of Pharmacy has proposed changes that will make labels easier to read and understand. » More
|
ADVERTISEMENT
Seeking a Proven Investment in Health Care…with NO third party payors?
Seeking a healthy investment or career? Appreciate good health? MMSN, a 24 y/o, 155-unit, sports nutrition franchise is expanding 10-fold into selected markets, creating opportunities for health care investors. Interested?  Learn More. |
|
FDA approved the first generic versions of Celebrex (celecoxib) last week. The drug is used to treat rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and other conditions. » More
|
|
Following the World Health Organization’s declaration that the spread of polio presents an international public health emergency, the Centers for Disease Control and Prevention issued a health advisory to clinicians regarding vaccinations. » More
|
Continuing Education
This month's article is the fifth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities form the University of Connecticut School of Pharmacy and Drug Topics.
The goal of this month's activity is to review the stages and pharmacologic strategies relevant to medication therapy management of heart failure.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
|
|
|
Like
Tweet
